ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis

Anthracyclines and trastuzumab are widely used to treat breast cancer but increase the risk of cardiomyopathy and heart failure. With the use of trastuzumab and anthracycline-containing medications, this study intends to evaluate the effectiveness and security of current treatments against cardiotox...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yu, Wang, Ruiting, Jiang, Jinchi, Hu, Yueyao, Li, Haijing, Wang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575808/
https://www.ncbi.nlm.nih.gov/pubmed/37414918
http://dx.doi.org/10.1007/s10741-023-10328-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575808/
https://www.ncbi.nlm.nih.gov/pubmed/37414918
http://dx.doi.org/10.1007/s10741-023-10328-z

Ejemplares similares